Holen Sie sich die Stockscreener-App
0.4501
2.10%
-0.0175
Schlusskurs vom Vortag:
$0.4676
Offen:
$0.49
24-Stunden-Volumen:
208.64K
Relative Volume:
0.34
Marktkapitalisierung:
$16.81M
Einnahmen:
$53.55M
Nettoeinkommen (Verlust:
$-15.13M
KGV:
-0.4168
EPS:
-1.08
Netto-Cashflow:
$-23.86M
1W Leistung:
-12.05%
1M Leistung:
+3.72%
6M Leistung:
-7.33%
1J Leistung:
-33.43%
1-Tages-Spanne:
$0.448
$0.49
1-Wochen-Bereich:
$0.448
$0.57
52-Wochen-Spanne:
$0.2801
$1.32
Cosmos Health Inc Stock (COSM) Company Profile
Firmenname
Cosmos Health Inc
Sektor
Branche
Telefon
312-536-3102
Adresse
5 AGIOU GEORGIOU, PILEA, THESSALONIKI
Vergleichen Sie COSM mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COSM
Cosmos Health Inc
|
0.4501 | 17.46M | 53.55M | -15.13M | -23.86M | -1.08 |
|
MCK
Mckesson Corporation
|
834.62 | 101.70B | 387.09B | 4.23B | 6.01B | 32.12 |
|
COR
Cencora Inc
|
349.18 | 67.10B | 321.33B | 1.57B | 3.21B | 7.9518 |
|
CAH
Cardinal Health Inc
|
212.08 | 49.48B | 234.31B | 1.61B | 4.45B | 6.6243 |
|
HSIC
Henry Schein Inc
|
75.47 | 8.93B | 12.50B | 314.00M | 421.00M | 2.44 |
|
AHG
Akso Health Group Adr
|
1.45 | 796.34M | 2.22M | -5.63M | -1.68M | -0.24 |
Cosmos Health Inc Aktie (COSM) Neueste Nachrichten
Cosmos Health CEO Siokas buys $57,000 in shares - Investing.com India
Sunday’s Insider Activity: Big Buys at Zenas, Hycroft, and Major NVDA Sell - Investing.com Nigeria
Is Cosmos Health Inc. stock a defensive play in 2025July 2025 Trends & Accurate Intraday Trading Signals - Улправда
Cosmos Health Announces Launch Of Food Supplement Brand In Albania: Retail Sentiment Improves - MSN
Is Cosmos Health Inc. stock a safe haven assetStability vs Neutral Overview & support options for steady strides - Улправда
Cosmos Health Inc.Common Stock (NQ: COSM - FinancialContent
Insider Stock Purchases: January 09, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $81,000 in shares By Investing.com - Investing.com Canada
Cosmos Health CEO Siokas buys $81,000 in shares - Investing.com
Why Cosmos Health Inc. stock could see breakout soonPortfolio Profit Report & Consistent Profit Alerts - Улправда
Why Cosmos Health Inc. (V67A) stock could be next leaderDividend Hike & Verified Technical Signals - Улправда
How Cosmos Health Inc. stock reacts to Fed rate cutsEarnings Overview Report & Daily Price Action Insights - Улправда
How currency fluctuations impact Cosmos Health Inc. stockJuly 2025 Snapshot & Fast Moving Trade Plans - ulpravda.ru
Layoff Watch: What catalysts could drive Cosmos Health Inc stock higherWeekly Volume Report & Free Technical Pattern Based Buy Signals - moha.gov.vn
Why Cosmos Health Inc. (V67A) stock trades below fair valueMarket Weekly Review & Technical Buy Zone Confirmation - ulpravda.ru
Why Cosmos Health Inc. stock could benefit from AI revolutionJobs Report & Expert Approved Momentum Ideas - Улправда
Cosmos Health CEO Siokas buys $65,000 in COSM stock By Investing.com - Investing.com South Africa
Cosmos Health CEO Siokas buys $65,000 in COSM stock - Investing.com
How Cosmos Health Inc. stock benefits from strong dollarJuly 2025 Closing Moves & Short-Term High Return Ideas - ulpravda.ru
Analysis Recap: How Cosmos Health Inc. stock reacts to Fed rate cuts2025 Institutional Moves & AI Driven Stock Movement Reports - Улправда
Insider Stock Purchases: January 07, 2026 - Quiver Quantitative
Cosmos Health CEO Siokas buys $72k in shares By Investing.com - Investing.com UK
Cosmos Health CEO Siokas buys $72k in shares - Investing.com
Cosmos Health to manufacture PathMuscle drug for Greek distributor By Investing.com - Investing.com Nigeria
Cosmos Health’s Wild Ride: Can COSM Survive Its Own Volatility? - AD HOC NEWS
Tangible book value per share of Cosmos Health Inc – MUN:V67A - TradingView — Track All Markets
Cosmos Health (COSM) Subsidiary to Manufacture PathMuscle for Li - GuruFocus
Cosmos Health stock rises on manufacturing deal with Libytec By Investing.com - Investing.com Nigeria
Cosmos Health stock rises on manufacturing deal with Libytec - Investing.com
Cosmos Health Inc. Subsidiary Cana Laboratories Enters Manufacturing Agreement for PathMuscle with Libytec Pharmaceutical in Greece - Quiver Quantitative
Cosmos Health to manufacture PathMuscle drug for Greek distributor - Investing.com
Cosmos Health Enters Manufacturing Agreement with Libytec - GlobeNewswire
About Us - FinancialContent
Cosmos Health Enters Manufacturing Agreement with Libytec for PathMuscle Medicine, with Five-Year Volumes Expected to Exceed 1.2 Million Units - Sahm
Cosmos Health Is Building a Platform, and Tariffs Are Accelerating the Strategy - ACCESS Newswire
How one healthcare supplier is remaking its business to dodge tariffs - Stock Titan
Cosmos Health receives Nasdaq non-compliance bid price notice - MSN
Siokas buys Cosmos Health (COSM) shares worth $43,000 By Investing.com - Investing.com Australia
Siokas buys Cosmos Health (COSM) shares worth $43,000 - Investing.com India
Cosmos Health CEO Acquires Shares Through Debt Exchange - TradingView — Track All Markets
Will Cosmos Health Inc. (V67A) stock benefit from mergers2025 Macro Impact & Weekly Return Optimization Plans - Улправда
Finanzdaten der Cosmos Health Inc-Aktie (COSM)
Umsatz
Nettogewinn
Free Cashflow
ENV
Cosmos Health Inc-Aktie (COSM) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Siokas Grigorios | Chief Executive Officer |
Jan 08 '26 |
Buy |
0.52 |
156,190 |
81,000 |
7,131,794 |
| Siokas Grigorios | Chief Executive Officer |
Jan 07 '26 |
Buy |
0.52 |
124,880 |
65,000 |
6,975,604 |
| Siokas Grigorios | Chief Executive Officer |
Jan 06 '26 |
Buy |
0.54 |
133,953 |
72,000 |
6,850,724 |
| Siokas Grigorios | Chief Executive Officer |
Dec 19 '25 |
Buy |
0.49 |
88,314 |
43,000 |
6,716,771 |
| Siokas Grigorios | Chief Executive Officer |
Dec 15 '25 |
Buy |
0.42 |
168,472 |
70,000 |
6,628,457 |
| Siokas Grigorios | Chief Executive Officer |
Nov 28 '25 |
Buy |
0.64 |
76,360 |
49,000 |
6,459,985 |
| Siokas Grigorios | Chief Executive Officer |
Nov 25 '25 |
Buy |
0.63 |
55,732 |
35,000 |
6,383,625 |
| Siokas Grigorios | Chief Executive Officer |
Nov 21 '25 |
Buy |
0.68 |
56,080 |
38,000 |
6,327,893 |
| Siokas Grigorios | Chief Executive Officer |
Nov 20 '25 |
Buy |
0.62 |
51,315 |
32,000 |
6,271,813 |
| Siokas Grigorios | Chief Executive Officer |
Nov 19 '25 |
Buy |
0.65 |
61,614 |
40,000 |
6,220,498 |
0.00%
3.42%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):